BTG2 Activators
The class of T-BTG2 activators comprises a diverse array of compounds with distinct mechanisms of action, collectively contributing to the activation of the BTG2 gene. These modulators exert their influence through intricate interactions with various cellular pathways. Curcumin, a polyphenolic compound, indirectly activates BTG2 by modulating the PI3K/AKT and MAPK pathways, showcasing its potential as a multifaceted modulator of BTG2 expression. Resveratrol, a natural stilbene, influences BTG2 activation through SIRT1-mediated AMPK pathway modulation, providing insights into its role in cellular stress response. Additionally, sulforaphane, an isothiocyanate, promotes BTG2 expression by modulating the Nrf2-mediated signaling pathway, highlighting its potential as a regulator of BTG2 in the context of cellular redox balance. Genistein, a soy-derived isoflavone, acts as an indirect activator of BTG2 by modulating estrogen receptor signaling and MAPK pathways, emphasizing its potential role in hormone-responsive contexts.
Furthermore, agents like cisplatin induce DNA damage and activate p53, leading to increased BTG2 expression. 5-Aza-2'-deoxycytidine, a DNA demethylating agent, promotes BTG2 activation by demethylating its promoter region, offering an epigenetic approach to modulate BTG2 expression. Trichostatin A, a histone deacetylase inhibitor, influences BTG2 expression through histone hyperacetylation, providing insights into epigenetic regulation of BTG2. Diallyl disulfide, an organosulfur compound, influences BTG2 expression by modulating Nrf2-mediated signaling, suggesting its potential in regulating BTG2 expression under conditions of oxidative stress. Epigallocatechin gallate (EGCG), a green tea polyphenol, exerts its effects on BTG2 through modulation of PI3K/AKT and MAPK pathways, showcasing its versatile role as a BTG2 modulator. Betulinic acid, a natural triterpenoid, affects the NF-κB signaling pathway, highlighting its potential as a regulator of BTG2 in the context of inflammation and immune responses.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a polyphenolic compound, indirectly activates BTG2. It modulates multiple pathways, including PI3K/AKT and MAPK, leading to increased BTG2 expression. Curcumin's anti-inflammatory properties and its ability to induce apoptosis contribute to BTG2 activation by influencing upstream signaling cascades. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a natural stilbene, indirectly activates BTG2. Through SIRT1 activation, it influences the AMPK pathway, leading to increased BTG2 expression. Resveratrol's role in cellular stress response and its impact on metabolic pathways contribute to BTG2 activation, suggesting its potential as a modulator of BTG2 expression in diverse cellular contexts. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane, an isothiocyanate, indirectly activates BTG2. It promotes Nrf2 nuclear translocation, leading to the upregulation of BTG2 expression. Sulforaphane's role as an inducer of phase II detoxification enzymes and its impact on cellular redox balance contribute to BTG2 activation by modulating the Nrf2-mediated signaling pathway. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a soy-derived isoflavone, indirectly activates BTG2. It modulates estrogen receptor signaling and influences MAPK pathways, leading to increased BTG2 expression. Genistein's role as a phytoestrogen and its impact on cellular proliferation contribute to BTG2 activation, providing insights into its potential as a regulator of BTG2 expression in hormone-responsive contexts. | ||||||
Emodin | 518-82-1 | sc-202601 sc-202601A sc-202601B | 50 mg 250 mg 15 g | $105.00 $214.00 $6255.00 | 2 | |
Emodin, an anthraquinone derivative, indirectly activates BTG2. It affects the Wnt/β-catenin pathway, leading to increased BTG2 expression. Emodin's role as a Wnt signaling inhibitor and its impact on cell cycle progression contribute to BTG2 activation by modulating the canonical Wnt pathway, suggesting its potential as a regulator of BTG2 expression in contexts where Wnt signaling is dysregulated. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin, a flavonoid, indirectly activates BTG2. It modulates multiple signaling pathways, including PI3K/AKT and MAPK, leading to increased BTG2 expression. Quercetin's antioxidant properties and its impact on cell cycle progression contribute to BTG2 activation, suggesting its potential as a versatile modulator of BTG2 expression in various cellular contexts. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a platinum-based chemotherapeutic, indirectly activates BTG2. It induces DNA damage and activates p53, leading to increased BTG2 expression. Cisplatin's role as a DNA crosslinking agent and its impact on cell cycle checkpoints contribute to BTG2 activation, suggesting its potential as a modulator of BTG2 expression in the context of DNA damage response and chemotherapeutic interventions. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2'-deoxycytidine, a DNA demethylating agent, indirectly activates BTG2. It promotes demethylation of the BTG2 promoter region, leading to increased gene expression. 5-Aza-2'-deoxycytidine's role in epigenetic modulation and its impact on chromatin structure contribute to BTG2 activation by influencing the methylation status of the BTG2 gene, suggesting its potential as an epigenetic regulator of BTG2 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, a histone deacetylase inhibitor, indirectly activates BTG2. It promotes histone hyperacetylation, leading to increased BTG2 expression. Trichostatin A's role in epigenetic regulation and its impact on chromatin structure contribute to BTG2 activation by modulating the acetylation status of histones associated with the BTG2 gene, suggesting its potential as an epigenetic modulator of BTG2 expression. | ||||||
Allyl disulfide | 2179-57-9 | sc-252359 | 25 g | $80.00 | ||
Diallyl disulfide, a garlic-derived organosulfur compound, indirectly activates BTG2. It influences Nrf2 nuclear translocation, leading to increased BTG2 expression. Diallyl disulfide's role as a modulator of cellular redox balance and its impact on phase II detoxification pathways contribute to BTG2 activation by modulating the Nrf2-mediated signaling pathway, suggesting its potential as a regulator of BTG2 expression in the context of oxidative stress. | ||||||